Cargando…

ePRO symptom follow-up of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy is feasible and enhances the quality of patient care: a prospective multicenter study

PURPOSE: Electronic (e) patient-reported outcomes (PROs) have been shown to improve the quality of life and survival in chemotherapy treated advanced cancer patients. We hypothesized that multidimensional ePRO centered approach could improve symptom management, streamline patient flow, and optimize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iivanainen, Sanna, Ravichandra, Ravi, Jekunen, Antti, Arokoski, Reetta, Mentu, Santeri, Lang, Laura, Ekström, Jussi, Virtanen, Henri, Kataja, Vesa, Koivunen, Jussi P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374742/ https://www.ncbi.nlm.nih.gov/pubmed/36809503 http://dx.doi.org/10.1007/s00432-023-04622-4

Ejemplares similares

ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study
por: Iivanainen, Sanna, et al.
Publicado: (2019)

Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies
por: Iivanainen, Sanna, et al.
Publicado: (2021)

Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study
por: Iivanainen, Sanna, et al.
Publicado: (2020)

Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers
por: Tikkanen, Antti, et al.
Publicado: (2020)

Possibilities of Improving the Clinical Value of Immune Checkpoint Inhibitor Therapies in Cancer Care by Optimizing Patient Selection
por: Iivanainen, Sanna, et al.
Publicado: (2020)

Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study
por: Kuusisalo, Saara, et al.
Publicado: (2022)

Tetracyclines increase the survival of NSCLC patients treated with EGFR TKIs: a retrospective nationwide registry study
por: Alanen, Virve, et al.
Publicado: (2020)

Assessment of chemotherapy‐induced neurotoxicity using a point‐of‐care nerve conduction study device
por: Jokimäki, Anna, et al.
Publicado: (2022)

Mobile eHealth solution (ePRO)
por: Saganowski, Stanisław, et al.
Publicado: (2015)

Feasibility of electronic patient-reported outcome monitoring and self-management program in aplastic anemia and paroxysmal nocturnal hemoglobinuria—a pilot study (ePRO-AA-PNH)
por: Bänziger, Silas, et al.
Publicado: (2022)

Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors
por: Iivanainen, Sanna, et al.
Publicado: (2019)

The prognostic and predictive roles of plasma C‐reactive protein and PD‐L1 in non‐small cell lung cancer
por: Kuusisalo, Saara, et al.
Publicado: (2023)

Electronic patient-reported outcome (ePRO) application for patients with prostate cancer
por: Mohseni, Majid, et al.
Publicado: (2023)

Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients
por: Schmalz, Oliver, et al.
Publicado: (2020)

Key methodological considerations for usability testing of electronic patient-reported outcome (ePRO) systems
por: Aiyegbusi, Olalekan Lee
Publicado: (2019)

Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of ePRO Measurement in Clinical Trials
por: Coons, Stephen Joel, et al.
Publicado: (2014)

ePro-ClearSee: a simple immunohistochemical method that does not require sectioning of plant samples
por: Nagaki, Kiyotaka, et al.
Publicado: (2017)

Content validity and ePRO usability of the BPI-sf and “worst pain” item with pleural and peritoneal mesothelioma
por: Gelhorn, Heather L., et al.
Publicado: (2018)

Erratum to: Capturing Patient-Reported Outcome (PRO) Data Electronically: The Past, Present, and Promise of ePRO Measurement in Clinical Trials
por: Coons, Stephen Joel, et al.
Publicado: (2015)

eProS—a database and toolbox for investigating protein sequence–structure–function relationships through energy profiles
por: Heinke, Florian, et al.
Publicado: (2013)

Implementation of a cloud-based electronic patient-reported outcome (ePRO) platform in patients with advanced cancer
por: Generalova, Olga, et al.
Publicado: (2021)

Feasibility study on collecting patient‐reported outcomes from breast cancer patients using the LINE‐ePRO system
por: Hayashida, Tetsu, et al.
Publicado: (2022)

Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative Treatment
por: Hofer, Silvia, et al.
Publicado: (2023)

Psychometric validation and testing of the 10-item pediatric daily chest-related electronic patient reported outcome (ePRO) diary
por: Arbuckle, Rob, et al.
Publicado: (2023)

Electronic patient-reported outcomes in clinical kidney practice (ePRO Kidney): a process evaluation of educational support for clinicians
por: Schick-Makaroff, Kara, et al.
Publicado: (2023)

The provider perspective: investigating the effect of the Electronic Patient-Reported Outcome (ePRO) mobile application and portal on primary care provider workflow
por: Hans, Parminder K., et al.
Publicado: (2017)

What ePROs are telling us about patients with substance use disorder
por: Krasteva, S., et al.
Publicado: (2022)

Clinical efficacy, safety, and subjective experience based on ePRO in HIV‐infected individuals administered Bictegravir/Emtricitabine/Tenofovir Alafenamide in southwest China
por: Kong, Linghong, et al.
Publicado: (2023)

Combining targeted drugs to overcome and prevent resistance of solid cancers with some stem-like cell features
por: Jokinen, Elina, et al.
Publicado: (2014)

Decision-making in product portfolios of pharmaceutical research and development – managing streams of innovation in highly regulated markets
por: Jekunen, Antti
Publicado: (2014)

Clinicians’ Expectations for Gene-Driven Cancer Therapy
por: Jekunen, Antti
Publicado: (2014)

A Study Protocol for the Management of Children With Juvenile Idiopathic Arthritis Based on ePROs
por: Shen, Biyu, et al.
Publicado: (2022)

A minimum assumption approach to MEG sensor array design
por: Zhdanov, Andrey, et al.
Publicado: (2023)

Role of Rebiopsy in Relapsed Non-Small Cell Lung Cancer for Directing Oncology Treatments
por: Jekunen, Antti P.
Publicado: (2015)

Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
por: Aitini, Enrico, et al.
Publicado: (2012)

Essential barriers and considerations for the implementation of electronic patient-reported outcome (ePRO) measures in oncological practice: contextualizing the results of a feasibility study with existing literature
por: Kiderlen, Til Ramón, et al.
Publicado: (2022)

Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial
por: McMullan, Christel, et al.
Publicado: (2023)

Alternative dosing of dual PI3K and MEK inhibition in cancer therapy
por: Jokinen, Elina, et al.
Publicado: (2012)

Prognostic and predictive role of tumour-associated macrophages in HER2 positive breast cancer
por: Honkanen, Tiia J., et al.
Publicado: (2019)

Adult onset epilepsy incidence in Finland over 34 years: A nationwide registry study
por: Sipilä, Jussi O. T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ule5gi4iejr6kgr6lvc89bub8